Chicago, IL – April 23, 2010 - Panthera Global, Inc. (“PGI”) is pleased to announce that it has been retained by a newly formed entity to raise up to $100 million of capital for the acquisitions of several companies operating within the specialty pharmaceutical industry. Through this mandate, the holding company will acquire leading providers of pharmaceuticals within the hemophilia space as well as other therapies such as IVIG and HIV. These companies also provide ancillary services and the necessary pharmacy supplies.